FDA vs EFSA Standards for Infant Formula - A Regulation-by-Regulation Comparison — The Infant Formula Atlas

By María López Botín · Mother of 2, researching infant formula and infant nutrition since 2018

FDA 21 CFR 107 (the US framework) and EU Regulation 2016/127 (which implements EFSA's 2014 scientific opinion) set the compositional rules for infant formula on opposite sides of the Atlantic. Both reference the international Codex Alimentarius Stan 72-1981, but they diverge on specific nutrient minimums and maximums, mandatory ingredients, labeling rules, and approved additives. These differences are why a European Stage 1 formula imported to the US isn't identical to a US brand, even when both brands are trying to do the same thing.

This article walks through the substantive differences, nutrient by nutrient, with the specific numeric values.

FDA 21 CFR 107 and EU Regulation 2016/127 set different nutrient specifications for infant formula. The EU has lower minimum iron (0.3 mg/100 kcal vs 1.8 mg/100 kcal FDA), mandatory DHA (not mandatory in FDA), stricter marketing claim rules, and stage-based regulation (Stage 1 for 0-6 months; follow-on for 6 and months). FDA has one broader 0-12 month category with higher iron floor and no mandatory DHA. Both are protective; they reflect different scientific reasoning about optimal nutrient levels, not one being 'safer' than the other.

Two regulatory frameworks, two philosophies

The underlying philosophies differ:

FDA 21 CFR Part 107 (1980, amended 1986)

Single age category: 0-12 months
Mostly minimum nutrient values; maximum values for a smaller set
DHA not mandatory
Allows higher iron fortification
Marketing claims more permissive
Pre-market notification required before sale
Annual facility inspection required
Administered by FDA with input from pediatric nutrition societies

For the full US regulatory framework, see FDA infant formula regulation.

EU Regulation 2016/127 (effective 2020 for infant formula)

Two age categories: infant formula (0-6 months), follow-on formula (6+ months)
Both minimums and maximums for most nutrients
DHA mandatory
Lower iron floor (but still adequate per EFSA scientific opinion)
Marketing claims tightly restricted
Based on EFSA 2014 scientific opinion on essential composition
National implementation by EU Member States

For the EU framework in detail, see EU infant formula regulation.

Side-by-side regulatory framework comparison. FDA 21 CFR 107 versus EU Regulation 2016/127 on infant formula composition, quality controls, and enforcement mechanisms — FDA 21 CFR 107 is broader on recall/enforcement, lighter on composition prescription. EU 2016/127 is prescriptive on composition (lactose predominance, mandatory DHA, upper nutrient limits) but lighter on recall teeth. Neither is strictly superior.

The nutrient-by-nutrient comparison

All values normalized to per-100-kcal where possible for direct comparison. Note that EU labels typically use per-100-ml format (see how to read a formula label for conversion).

Energy density

Parameter	FDA	EU
Energy content	Not explicitly regulated; typical 20 kcal/fl oz (~67 kcal/100 ml)	60-70 kcal/100 ml (Stage 1)
Approach	De facto standard	Explicit range

Similar practical values. The EU's explicit range rules out unusually high or low density products.

Protein

Parameter	FDA	EU Stage 1	EU Follow-On
Minimum	1.8 g/100 kcal	1.8 g/100 kcal	1.8 g/100 kcal
Maximum	4.5 g/100 kcal	2.5 g/100 kcal	2.5 g/100 kcal
Quality requirement	Amino acid pattern	PDCAAS / DIAAS references	PDCAAS / DIAAS references

The EU sets a much lower protein ceiling. This is deliberate, excessive protein in early infancy is associated with increased obesity risk (the "protein-obesity hypothesis"). EU formulas are structurally lower-protein on average.

Fat

Parameter	FDA	EU Stage 1	EU Follow-On
Minimum fat	3.3 g/100 kcal	4.4 g/100 kcal	4.0 g/100 kcal
Maximum fat	6.0 g/100 kcal	6.0 g/100 kcal	6.0 g/100 kcal
Linoleic acid min	300 mg/100 kcal	500 mg/100 kcal	500 mg/100 kcal
Alpha-linolenic acid min	None specified	50 mg/100 kcal	50 mg/100 kcal

The EU sets higher fat minimums and specifies alpha-linolenic acid (ALA, omega-3 precursor) minimums that the FDA does not.

DHA (docosahexaenoic acid)

Parameter	FDA	EU Stage 1	EU Follow-On
Mandatory?	No	Yes (since 2020)	Yes
Minimum	Not specified	20 mg/100 kcal	20 mg/100 kcal
Maximum	Not specified	50 mg/100 kcal	50 mg/100 kcal

This is the single biggest regulatory difference. Since February 2020, all infant formulas sold in the EU must contain DHA at specified levels. In the US, DHA is optional, though most modern US formulas include it, some budget or specialty products still do not.

For the underlying discussion see our DHA explainer and ARA explainer.

Carbohydrate

Parameter	FDA	EU Stage 1	EU Follow-On
Minimum total carb	9.0 g/100 kcal	9.0 g/100 kcal	9.0 g/100 kcal
Maximum total carb	None specified	14.0 g/100 kcal	14.0 g/100 kcal
Lactose required as primary	No explicit rule	Yes (Stage 1)	Not required (Stage 2+)
Added sugars (sucrose)	Permitted with restrictions	Strict limits	Strict limits

EU Stage 1 explicitly requires lactose as the primary carbohydrate — this is why European Stage 1 formulas are generally lactose-first. The FDA has no equivalent rule, which is why some US formulas (like Happy Baby Organic Infant) use maltodextrin or glucose syrup solids as primary carbs even for Stage 1.

See our lactose explainer and maltodextrin explainer.

Iron

Parameter	FDA	EU Stage 1	EU Follow-On
Minimum iron	1.0 mg/100 kcal ("low-iron" variant) to 1.8 mg/100 kcal	0.3 mg/100 kcal	0.6 mg/100 kcal
Maximum iron	3.0 mg/100 kcal	1.3 mg/100 kcal	2.0 mg/100 kcal

This is the second-biggest regulatory difference. US formulas typically contain 2-3x more iron than EU Stage 1 formulas. The EFSA scientific opinion argues that the EU minimum is adequate because:

Infants are born with iron stores sufficient for ~4-6 months
Excessive iron fortification may negatively affect gut microbiota
The US higher floor dates from decades of preventing iron deficiency anemia in at-risk populations

Practical implication: a US baby switching from US formula to imported European Stage 1 receives less iron. For infants at elevated deficiency risk (preemies, low-birth-weight, specific medical conditions) the US level is clinically preferable. For healthy term infants, both levels are adequate.

See our iron explainer for the full discussion.

Sodium

Parameter	FDA	EU Stage 1	EU Follow-On
Minimum sodium	20 mg/100 kcal	25 mg/100 kcal	25 mg/100 kcal
Maximum sodium	60 mg/100 kcal	60 mg/100 kcal	60 mg/100 kcal

Similar ranges. Both frameworks aim to prevent excessive salt load on immature infant kidneys.

Calcium and phosphorus

Parameter	FDA	EU Stage 1	EU Follow-On
Calcium min	60 mg/100 kcal	50 mg/100 kcal	50 mg/100 kcal
Calcium max	None specified	140 mg/100 kcal	140 mg/100 kcal
Phosphorus min	30 mg/100 kcal	25 mg/100 kcal	25 mg/100 kcal
Ca:P ratio	1.1 to 2.0	1.0 to 2.0	1.0 to 2.0

Both frameworks specify Ca:P ratio to ensure bone mineralization balance. Similar values.

Vitamin A

Parameter	FDA	EU Stage 1	EU Follow-On
Minimum	250 IU/100 kcal	216 IU/100 kcal	216 IU/100 kcal
Maximum	750 IU/100 kcal	538 IU/100 kcal	538 IU/100 kcal

Both frameworks permit approximately similar ranges. The EU is slightly more restrictive on the upper end.

Vitamin D

Parameter	FDA	EU Stage 1	EU Follow-On
Minimum	40 IU/100 kcal (1.0 μg/100 kcal)	80 IU/100 kcal (2.0 μg/100 kcal)	80 IU/100 kcal
Maximum	100 IU/100 kcal	100 IU/100 kcal	140 IU/100 kcal

The EU requires 2x more vitamin D minimum. This reflects EFSA's position on vitamin D adequacy in formula-fed infants.

Folate

Parameter	FDA	EU Stage 1	EU Follow-On
Minimum	4 μg/100 kcal (as folic acid)	11 μg DFE/100 kcal	11 μg DFE/100 kcal
Form specification	Generally folic acid	Folic acid or Metafolin (L-methylfolate) permitted	Same

The EU permits Metafolin (L-methylfolate), the bioactive form of folate, as an alternative to folic acid. Some premium European formulas (including HiPP Combiotik) use Metafolin. US formulas typically use folic acid.

For a detailed explainer see our Metafolin vs folic acid pillar.

Iodine

Parameter	FDA	EU Stage 1	EU Follow-On
Minimum	5 μg/100 kcal	15 μg/100 kcal	15 μg/100 kcal
Maximum	75 μg/100 kcal	29 μg/100 kcal	29 μg/100 kcal

The EU sets a much lower iodine ceiling. This is based on EFSA concerns about excessive iodine affecting thyroid function in infants.

Mandatory additions: a quick reference

Ingredient	FDA	EU
DHA (omega-3)	Optional	Mandatory (Stage 1 and follow-on)
ARA (omega-6)	Optional	Optional but typical
Taurine	Optional	Optional
L-carnitine	Optional	Mandatory
Nucleotides	Optional	Optional
GOS/FOS prebiotics	Optional	Optional
2'-FL HMO	Optional	Optional but increasingly regulated

Banned or restricted ingredients

EU restrictions

Added sugars (sucrose), strict limits; cannot be the primary carbohydrate in Stage 1
Genetically modified ingredients, only permitted if specifically authorized
Hydrogenated fats, prohibited
Artificial flavors, prohibited
Artificial colors, prohibited
Irradiated ingredients, prohibited

FDA restrictions

Many of the EU-banned ingredients also restricted or de facto unused
Carrageenan, allowed but debated; used in some RTF liquid formulas
BHT (preservative), allowed in small amounts; European formulas typically avoid

Marketing and label claims

FDA permits (EU does not)

"Closer to breast milk" type claims
Direct marketing to parents of newborns in hospitals (WHO Code compliance is voluntary)
"Gentle," "Comfort," "Sensitive" with limited clinical evidence
Images suggesting health benefits

EU prohibits (FDA permits)

Images of babies on infant formula packaging
Direct-to-consumer marketing of infant formula (0-6 months) in many countries
Comparative claims to breast milk
"Closest to breast milk" language

The EU implements the WHO International Code of Marketing of Breast-milk Substitutes more strictly than the US does. This is why EU-labeled formula packaging looks visually different (less emotionally-appealing imagery, more clinical presentation).

Pre-market authorization process

US (FDA)

Manufacturer submits notification with nutrient analysis, clinical or historical evidence, and manufacturing details
FDA has 90 days to review and object
No full approval required, if FDA doesn't object, product can enter market
Annual facility inspection required
Recall authority if issues emerge

EU (via EFSA and national authorities)

Manufacturers must comply with Commission Regulation 2016/127
Member State competent authorities enforce
EFSA provides scientific opinions on contested ingredients
Post-market surveillance through RASFF (Rapid Alert System for Food and Feed)

Both systems have gaps. The 2022 Abbott Cronobacter event revealed FDA oversight weaknesses; EU inspection quality varies by Member State. Neither system is immune to contamination events. See our Abbott 2022 recall aftermath and US formula recall history pillars for the documented event record.

Codex Alimentarius: the international baseline

Both the FDA and EU standards reference Codex Alimentarius Stan 72-1981 (with 2007 and 2011 amendments). Codex sets voluntary international standards that many non-US, non-EU countries adopt. The FDA and EU standards are both stricter than Codex in most respects.

For imports into either jurisdiction, Codex compliance is generally a minimum threshold, not sufficient for US or EU sale, but the baseline for many other countries.

Practical implications for parents

If you switch from US formula to imported European

Lower iron intake per feeding (clinically acceptable for most; monitor if at elevated deficiency risk)
DHA mandatory, so guaranteed present
Lactose as primary carb in Stage 1 (better mimics breast milk composition)
Lower protein on average (may reduce weight gain slightly)
Stricter stage boundaries (6 months for Stage 2)

If you switch from European to US formula

Higher iron, higher protein
Lactose as primary carb is brand-dependent, not rule-required
DHA may or may not be present
Single 0-12 month product; no explicit stage boundary

Regulatory quality per se

Neither system is intrinsically "safer" than the other. Both have produced failures (Sturgis 2022 in US; various smaller EU events). Both have produced decades of safe commercial infant formula. The differences are scientific reasoning about nutrient optima, not safety floor differences.

FAQ

Is European baby formula safer than US formula?

Neither regulatory system is intrinsically safer. Both have rigorous standards but different scientific reasoning on specific nutrient levels. EU Regulation 2016/127 has mandatory DHA, lower protein and iron ceilings, stricter lactose-first rules for Stage 1, and more conservative marketing claim rules. FDA 21 CFR 107 has higher iron minimums and more flexibility on carbohydrate composition. Both have experienced contamination events and recalls.

Why does EU baby formula have less iron than US formula?

EU Stage 1 requires 0.3 mg iron/100 kcal minimum vs FDA's 1.0-1.8 mg/100 kcal. EFSA's scientific opinion argues that infants have adequate iron stores for 4-6 months and excessive fortification may affect gut microbiota negatively. The FDA higher floor was historically set to prevent iron deficiency in at-risk populations. For healthy term infants both levels are adequate; preemies or medically complex infants may benefit from the US level.

Is DHA required in all infant formulas?

In the EU, yes, since 2020, DHA is mandatory in all infant formula sold in the EU under Regulation 2016/127. In the US, no: DHA is optional under FDA 21 CFR 107. Most modern US formulas include DHA voluntarily; some budget or specialty products do not. Check the label. DHA is a major component of brain fat and is present in breast milk naturally.

Why is European Stage 1 always lactose-based?

EU Regulation 2016/127 requires lactose as the primary carbohydrate in Stage 1 (0-6 months) infant formula. This is the carbohydrate present in breast milk in large quantities. In the US, no equivalent rule exists, so some Stage 1 formulas use maltodextrin or glucose syrup solids as primary carbs. See our 'How to Read a Formula Label' pillar for ingredient-list decoding.

Are there ingredients banned in EU formula but allowed in US formula?

Yes. The EU more strictly regulates added sugars (sucrose), carrageenan, certain preservatives, artificial flavors, and genetically modified ingredients. Some US formulas contain carrageenan or higher levels of added sugars that would not be permitted in EU-sold formulas. Marketing claim rules are also stricter in EU.

Does the EU allow different stages of formula?

Yes. EU Regulation 2016/127 defines two categories: infant formula (0-6 months) and follow-on formula (6+ months). Commercial branding typically labels these as Stage 1, Stage 2, and Stage 3 (the last being 10-18 months, a marketing extension of follow-on). US regulation defines a single category covering 0-12 months. See our 'When to switch formula stages' pillar for the clinical framework.

How do European formulas meet US regulations?

Formally, they don't: European formulas are not FDA-registered under 21 CFR 107 and are therefore not legally sold by major US retailers. FDA enforcement discretion, established during the 2022 Abbott crisis, allows personal-use imports of specific European brands. Some brands (Kendamil) have obtained FDA enforcement discretion status allowing limited US retail presence. See our FDA infant formula regulation and buying European formula USA pillars.

Are there international baby formula standards?

Yes: Codex Alimentarius Stan 72-1981 sets voluntary international standards referenced by both FDA and EU regulators. Codex sets minimum composition requirements that many non-US, non-EU countries adopt. Both the FDA and EU standards are stricter than Codex in most respects. For global imports, Codex compliance is the baseline requirement.

Primary sources

FDA 21 CFR Part 107: Infant Formula regulation. ecfr.gov
EU Regulation 2016/127: Infant formula and follow-on formula. eur-lex.europa.eu
EFSA: Scientific Opinion on the essential composition of infant and follow-on formulae. 2014. efsa.europa.eu
Codex Alimentarius: Stan 72-1981: Standard for Infant Formula. fao.org
WHO: International Code of Marketing of Breast-milk Substitutes. who.int

Brands and comparisons that make this regulatory split concrete, HiPP brand hub (EU-2016/127 compliant, FDA enforcement discretion), Bobbie brand hub (FDA-registered under 21 CFR 107 and USDA Organic), and the six EU-vs-US product decisions expressed as comparison articles: HiPP Dutch Stage 1 vs Bobbie Original, HiPP Dutch Stage 1 vs Similac Pro-Advance, Enfamil NeuroPro vs HiPP Dutch Stage 1, Enfamil NeuroPro vs Holle Cow Stage 1, Holle Cow Stage 1 vs Similac Pro-Advance, Enfamil NeuroPro vs Kendamil Classic Stage 1, and Kendamil Classic Stage 1 vs Similac Pro-Advance, Earth's Best Dairy vs HiPP Dutch Stage 1, and Happy Baby Organic Infant vs HiPP Dutch Stage 1 (the maltodextrin-vs-lactose-predominance divergence at the product level)
Is European formula safer than US formula?, the safety-comparison question answered with real recall data
EU Regulation 2016/127 overview
FDA 21 CFR 107 explained

This site provides research and comparisons, not medical advice. Consult your pediatrician before changing your baby's formula.